Apraclonidine (ALO 2145) dihydrochloride is a selective α2 and weak α1 receptor agonist that effectively reduces intraocular pressure (IOP) in the eyes. It is available as a topical ophthalmic solution [1] [2].
Aftobetin, also known as ANCA11 and NCE-11, is a novel amyloid–binding compound applied topically in the form of an ophthalmic ointment. Aftobetin may be of useful as an aid in the diagnosis Alzheimer's disease.